Skip to content

Comorbidities and Risk Factors

  • Global Asthma Prevalence – Global Burden of Disease 2021

    According to the Global Burden of Disease study 2021, a systematic review and meta-analysis including data from 389 sources for asthma reported that in 2021 there was: an estimated 260 million people with asthma worldwide forecast to reach 275 million people having asthma in 2050 age standardised prevalence: 3340 per 100,000 in 2021, a 40%…

    Read More Global Asthma Prevalence – Global Burden of Disease 2021Continue

  • Quality of life 2022 (AIHW, NHS 2022)

    According to self-reported data from the NHS 2022, amongst people with asthma aged 18 and over: – 19% reported that asthma interfered with daily activities 2 or more times in the past 4 weeks (vs 23% in 2017-18), including going to school or work, playing with friends, exercising, getting around places etc. – 8.8% experienced…

    Read More Quality of life 2022 (AIHW, NHS 2022)Continue

  • Risk factors – Asthma Burden of Disease (AIHW 2024)

    Risk factors – Asthma Burden of Disease (AIHW 2024) Risk factors attributable burden of asthma: the Burden of Disease study estimated that in 2024: – 36% of asthma total burden was due/attributed to all risk factors combined – 24% was due/attributed to being overweight (including obesity) – 7% was due/attributed to tobacco use – 5%…

    Read More Risk factors – Asthma Burden of Disease (AIHW 2024)Continue

  • Burden of disease 2024 (AIHW)

    In 2024, Asthma was the 10th leading contributor to the total burden of disease in Australia with a disability-adjusted life years (DALY) rate of 5.35 per 1,000 population (143,782 DALY, crude number), similar to 2023 – After adjustment for age structure, asthma was the 8th leading cause of total burden, with an age-standardised DALY rate…

    Read More Burden of disease 2024 (AIHW)Continue

  • Prevalence, National Aboriginal and Torres Strait Islander Health Survey 2022-2023 (ABS)

    The National Aboriginal and Torres Strait Islander Health Survey for the financial year 2022-2023  reported: • 16.6% has asthma, up from 15.7% in 2018-2019 (note that the difference between 2018-2019 and 2022-2023 was not statistically significant) • Asthma was the second most prevalent selected chronic condition after mental and behavioural conditions • By remoteness: 18.2%…

    Read More Prevalence, National Aboriginal and Torres Strait Islander Health Survey 2022-2023 (ABS)Continue

  • Comorbidities 2022 (AIHW)

    Prevalence data based on the National Health Survey 2022 indicated that: – about 1.8 million (65%) of people living with asthma also had one or more chronic condition – the top three comorbidities were: mental and behavioural conditions (41%), back problems (25%) and arthritis (23%)

    Read More Comorbidities 2022 (AIHW)Continue

  • Comorbidities in Difficult-To-Treat asthma (2021)

    A Cross-sectional survey of 6048 adult Australians with current asthma in the community (conducted in Feb-March 2021 during Covid measures) found that: – 21.7% had difficult-to-treat asthma (DTTA) – 85.4% of the participants with DTTA had at least 1 other chronic condition (comorbidity) Note: DTTA was defined as severe asthma and/or poor asthma control and/or…

    Read More Comorbidities in Difficult-To-Treat asthma (2021)Continue

  • Mental Health 2022 (Australian Government Productivity Commission)

    N/A

    Read More Mental Health 2022 (Australian Government Productivity Commission)Continue

  • Smoking prevalence among people with asthma in 2022 (ABS)

    N/A

    Read More Smoking prevalence among people with asthma in 2022 (ABS)Continue

  • Comorbidities 2020-2021 (AIHW)

    N/A

    Read More Comorbidities 2020-2021 (AIHW)Continue

Page navigation

1 2 Next PageNext

© 2026 DAISY Knowledge Library